Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Herman

Showing results (51-60 of 354) with videos related to

Pageof 36
Sort By:
Clinical Pediatrics|May 17, 2013
Effects of hypothetical type 2 diabetes genetic testing on parents' efforts to prevent diabetes in childrenBeth A Tarini, William H Herman, Joyce M Lee
Plos One|February 26, 2020
Severe obesity and the impact of medical weight loss on estimated glomerular filtration rateAmy E Rothberg, Laura N McEwen, William H Herman
Diabetes Care|December 24, 2005
Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trialLaurence Kennedy, William H Herman, Poul Strange, et al.
Diabetes Care|February 25, 2018
Changes in Health Insurance Coverage Under the Affordable Care Act: A National Sample of U.S. Adults With Diabetes, 2009 and 2016Sarah S Casagrande, Laura N McEwen, William H Herman
Diabetes Care|June 27, 2020
Erratum. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A<sub>1c</sub> Testing. Diabetes Care 2019;42:576-584Joshua M Evron, William H Herman, Laura N McEwen
Journal of Diabetes and Its Complications|April 27, 2021
Prediction of transient ischemic attack and minor stroke in people with type 2 diabetes mellitusDeanna J M Isaman, William H Herman, Wen Ye
American Journal of Epidemiology|March 26, 2013
Performance-based physical functioning and peripheral neuropathy in a population-based cohort of women at midlifeKelly R Ylitalo, William H Herman, Siobán D Harlow
Primary Care Diabetes|July 31, 2013
Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucoseKelly R Ylitalo, William H Herman, Siobán D Harlow
Diabetes Care|February 8, 2019
Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A<sub>1c</sub> TestingJoshua M Evron, William H Herman, Laura N McEwen
Diabetes Research and Clinical Practice|May 7, 2018
Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trialShihchen Kuo, Wen Ye, Justin Duong, et al.
Pageof 36

Showing results (51-60 of 354) with videos related to

Sort By:
Pageof 36
Clinical Pediatrics|May 17, 2013
Effects of hypothetical type 2 diabetes genetic testing on parents' efforts to prevent diabetes in childrenBeth A Tarini, William H Herman, Joyce M Lee
Plos One|February 26, 2020
Severe obesity and the impact of medical weight loss on estimated glomerular filtration rateAmy E Rothberg, Laura N McEwen, William H Herman
Diabetes Care|December 24, 2005
Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trialLaurence Kennedy, William H Herman, Poul Strange, et al.
Diabetes Care|February 25, 2018
Changes in Health Insurance Coverage Under the Affordable Care Act: A National Sample of U.S. Adults With Diabetes, 2009 and 2016Sarah S Casagrande, Laura N McEwen, William H Herman
Diabetes Care|June 27, 2020
Erratum. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A<sub>1c</sub> Testing. Diabetes Care 2019;42:576-584Joshua M Evron, William H Herman, Laura N McEwen
Journal of Diabetes and Its Complications|April 27, 2021
Prediction of transient ischemic attack and minor stroke in people with type 2 diabetes mellitusDeanna J M Isaman, William H Herman, Wen Ye
American Journal of Epidemiology|March 26, 2013
Performance-based physical functioning and peripheral neuropathy in a population-based cohort of women at midlifeKelly R Ylitalo, William H Herman, Siobán D Harlow
Primary Care Diabetes|July 31, 2013
Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucoseKelly R Ylitalo, William H Herman, Siobán D Harlow
Diabetes Care|February 8, 2019
Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A<sub>1c</sub> TestingJoshua M Evron, William H Herman, Laura N McEwen
Diabetes Research and Clinical Practice|May 7, 2018
Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trialShihchen Kuo, Wen Ye, Justin Duong, et al.
Pageof 36